Company intelligence / Profile preview

Salvona Technologies

Hamilton, New Jersey, United Statessalvona.com ↗

Ownership: Private
Development stage: Other

Overview

Salvona’s encapsulation platforms have demonstrated enhanced stability, controlled release, improved bioavailability of actives, reduced irritation potential, and customizable triggers for ingredient release. Their systems are widely adopted by global skincare and personal care brands; however, clinical results per se are not published as they provide enabling technology rather than finished pharmaceuticals[2][3][5].

Modalities: Nanoparticle (microencapsulation, sub-micron encapsulation)Polymer-drug conjugate therapy (for topical delivery systems)
Industry: Chemicals & Materials

Partnerships

Not specifically listed. The company works with global CPG brands and has a network of distributors/partners worldwide.

Beyond the preview

Go deeper on Salvona Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salvona Technologies.

Explore the full profile